What is Xtant Medical Holdings Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Xtant Medical Holdings's interest expense for the
three
months ended in Mar. 2024 was $ -0.8 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.2 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Xtant Medical Holdings's Operating Income for the
three
months ended in Mar. 2024 was $ -3.5 Mil. Xtant Medical Holdings's Interest Expense for the
three
months ended in Mar. 2024 was $ -0.8 Mil.
Xtant Medical Holdings did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Xtant Medical Holdings Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings (AMEX:XTNT) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Xtant Medical Holdings's Interest Expense for the
three
months ended in Mar. 2024 was $-0.8 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $-3.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $17.6 Mil.
Xtant Medical Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
| Xtant Medical Holdings did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Xtant Medical Holdings (Xtant Medical Holdings) Business Description
Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Executives
| Kevin D Brandt |
officer: VP & Chief Commercial Officer |
11621 RESEARCH CIRCLE, ALACHUA FL 32615 |
| Lori D Mitchell-keller |
director |
664 CRUISER LANE, BELGRADE MT 59714 |
| Jonn R. Beeson |
director |
664 CRUISER LANE, BELGRADE MT 59714 |
| Scott C Neils |
officer: Interim CFO |
664 CRUISER LANE, BELGRADE MT 59714 |
| Mark A. Schallenberger |
officer: Chief Operations Officer |
664 CRUISER LANE, BELGRADE MT 59714 |
| Sean E Browne |
officer: President and CEO |
664 CRUISER LANE, BELGRADE MT 59714 |
| Stavros G. Vizirgianakis |
director |
1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016 |
| Orbimed Rof Ii Llc |
director, 10 percent owner |
601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022 |
| Greg Jensen |
officer: VP, Finance and Interim CFO |
664 CRUISER LANE, BELGRADE MT 59714 |
| Ronald G. Berlin |
officer: VP & Chief Operations Officer |
664 CRUISER LANE, BELGRADE MT 59714 |
| Kathie J. Lenzen |
officer: SVP Fiance & Admin. & CFO |
664 CRUISER LANE, BELGRADE MT 59714 |
| Orbimed Advisors Llc |
10 percent owner |
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
| Matthew Rizzo |
director, 10 percent owner |
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
| Michael Eggenberg |
director, 10 percent owner |
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
| Robert Mcnamara |
director |
C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750 |
Xtant Medical Holdings (Xtant Medical Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTNT has been successfully added to your 